A severe epidemic of meningococcal meningitis in Nigeria, 1996. (Q34510684)

2 August 2017

A severe epidemic of meningococcal meningitis in Nigeria, 1996. (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

meningococcal meningitis

1 reference

Mohammed I

1

1 reference

2 August 2017

Nasidi A

2

1 reference

2 August 2017

Alkali AS

3

1 reference

2 August 2017

Garbati MA

4

1 reference

2 August 2017

Ajayi-Obe EK

5

1 reference

2 August 2017

Audu KA

6

1 reference

2 August 2017

Usman A

7

1 reference

2 August 2017

Abdullahi S

8

1 reference

2 August 2017

1 May 2000

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

2 August 2017

1 reference

2 August 2017

94

1 reference

2 August 2017

3

1 reference

2 August 2017

265-270

1 reference

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

The effect of rifampicin on meningococcal carriage in family contacts in northern Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Control of epidemic group A meningococcal meningitis in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Human immunity to the meningococcus. I. The role of humoral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Manson Lecture. Meningococcal meningitis in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Control of meningococcal infection in the African meningitis belt by selective vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

The duration of the antibody response to meningococcal vaccination in an African village

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Mortality from meningococcal disease during an epidemic in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

The immunological response to polyvalent meningococcal vaccine in Bauchi State, Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Control of epidemic meningococcal meningitis by mass vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Intercontinental spread of an epidemic group A Neisseria meningitidis strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Detection of meningitis epidemics in Africa: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Prophylactic Vaccination in Epidemic Meningococcal Meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Meningitis outbreaks and vaccination strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

An experiment in the prevention of meningococcal meningitis in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Single injection treatment of meningococcal meningitis 2. Long-acting chloramphenicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Response of children to Neisseria meningitidis polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2800%2990316-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0035-9203(00)90316-X

1 reference

2 August 2017

1 reference